glp 1 agonist and pregnancy Maternal GLP-1 receptor activation inhibits fetal growth Maternal cardiometabolic health and the
Description
10.4103/NRR.NRR-D-24-00001 60 SteinJ
Patients should be observed carefully for signs and symptoms of pancreatitis (e.g
By stabilising blood glucose within target ranges, GLP-1 receptor agonists may alleviate these symptoms, leading to a subjective sense of having more energy throughout the day
After that, if tolerated and under the supervision of your prescriber, the dose can be slowly increased up to 2.4 mg once a week
GLP-1 medications mimic the action of glucagon-like peptide-1, a naturally occurring hormone
The graphical abstract was created using BioRender
